Patients with congestive heart failure will be assessed for safety and clinical effects of Tolvaptan 30 mg every day versus 15 mg twice a day over a period of 7 days.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
40
Central Cardiology Medical Clinic
Bakersfield, California, United States
University of California-San Diego
San Diego, California, United States
University of Miami/Jackson Memorial Hospital
Miami, Florida, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Medical Research Institute
Slidell, Louisiana, United States
Androscoggin Cardiology Associates
Auburn, Maine, United States
University of Missouri-Kansas City School of Medicine
Kansas City, Missouri, United States
Saint Louis University
St Louis, Missouri, United States
Cardiology of Oklahoma
Tulsa, Oklahoma, United States
Medical University of South Carolina
Charleston, South Carolina, United States